Transfusion-associated graft versus host disease (TAGVHD)-with reference to neonatal period

Sanjay G. Gokhale, Sankalp S. Gokhale

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transfusion-associated graft versus host disease [TAGVHD] results from the engraftment of transfused immuno-competent cells in blood transfusion recipients, whose immune system is unable to reject them. All blood products containing viable, immuno-competent T cells have been implicated in TAGVHD. Presence of a "one-way HLA match between donor and recipient" is associated with a significantly increased risk of TAGVHD. Though sharing of haplotype is the most probable explanation, it is far from adequate. Since TAGVHD is not seen in patients with AIDS, and an acute GVHD-like syndrome has been noted in some identical twins and autologous (self) transplants, some other processes, possibly of an "autoimmune" nature are responsible for TAGVHD. Most of the cases have been reported from Japan. This clustering in space and time is rather intriguing. We offer here alternative hypothesis. Foetal and then neonatal lymphocytes exhibit tolerance towards donor cytotoxic T lymphocytes; and consequently very few cases of TAGVHD have been reported in neonates than expected. This tolerance is a part of altered immunology of pregnancy. We feel that it is possible to use maternal blood for transfusion to her newborn baby by following certain protocol and procedure and TAGVHD is no barrier.

Original languageEnglish (US)
Pages (from-to)700-704
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume28
Issue number6
DOIs
StatePublished - Apr 1 2015

Fingerprint

Graft vs Host Disease
Blood Transfusion
Space-Time Clustering
Tissue Donors
Newborn Infant
Monozygotic Twins
Autografts
Cytotoxic T-Lymphocytes
Allergy and Immunology
Haplotypes
Immune System
Japan
Acquired Immunodeficiency Syndrome
Mothers
Lymphocytes
T-Lymphocytes
Pregnancy

Keywords

  • Autoimmune processes
  • Fetomaternal tolerance
  • Haplotype sharing
  • Rarity in newborns
  • TAGVHD

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Transfusion-associated graft versus host disease (TAGVHD)-with reference to neonatal period. / Gokhale, Sanjay G.; Gokhale, Sankalp S.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 28, No. 6, 01.04.2015, p. 700-704.

Research output: Contribution to journalArticle

@article{30afa90eef7e4b56b4d5891bfa2854ee,
title = "Transfusion-associated graft versus host disease (TAGVHD)-with reference to neonatal period",
abstract = "Transfusion-associated graft versus host disease [TAGVHD] results from the engraftment of transfused immuno-competent cells in blood transfusion recipients, whose immune system is unable to reject them. All blood products containing viable, immuno-competent T cells have been implicated in TAGVHD. Presence of a {"}one-way HLA match between donor and recipient{"} is associated with a significantly increased risk of TAGVHD. Though sharing of haplotype is the most probable explanation, it is far from adequate. Since TAGVHD is not seen in patients with AIDS, and an acute GVHD-like syndrome has been noted in some identical twins and autologous (self) transplants, some other processes, possibly of an {"}autoimmune{"} nature are responsible for TAGVHD. Most of the cases have been reported from Japan. This clustering in space and time is rather intriguing. We offer here alternative hypothesis. Foetal and then neonatal lymphocytes exhibit tolerance towards donor cytotoxic T lymphocytes; and consequently very few cases of TAGVHD have been reported in neonates than expected. This tolerance is a part of altered immunology of pregnancy. We feel that it is possible to use maternal blood for transfusion to her newborn baby by following certain protocol and procedure and TAGVHD is no barrier.",
keywords = "Autoimmune processes, Fetomaternal tolerance, Haplotype sharing, Rarity in newborns, TAGVHD",
author = "Gokhale, {Sanjay G.} and Gokhale, {Sankalp S.}",
year = "2015",
month = "4",
day = "1",
doi = "10.3109/14767058.2014.928859",
language = "English (US)",
volume = "28",
pages = "700--704",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Transfusion-associated graft versus host disease (TAGVHD)-with reference to neonatal period

AU - Gokhale, Sanjay G.

AU - Gokhale, Sankalp S.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Transfusion-associated graft versus host disease [TAGVHD] results from the engraftment of transfused immuno-competent cells in blood transfusion recipients, whose immune system is unable to reject them. All blood products containing viable, immuno-competent T cells have been implicated in TAGVHD. Presence of a "one-way HLA match between donor and recipient" is associated with a significantly increased risk of TAGVHD. Though sharing of haplotype is the most probable explanation, it is far from adequate. Since TAGVHD is not seen in patients with AIDS, and an acute GVHD-like syndrome has been noted in some identical twins and autologous (self) transplants, some other processes, possibly of an "autoimmune" nature are responsible for TAGVHD. Most of the cases have been reported from Japan. This clustering in space and time is rather intriguing. We offer here alternative hypothesis. Foetal and then neonatal lymphocytes exhibit tolerance towards donor cytotoxic T lymphocytes; and consequently very few cases of TAGVHD have been reported in neonates than expected. This tolerance is a part of altered immunology of pregnancy. We feel that it is possible to use maternal blood for transfusion to her newborn baby by following certain protocol and procedure and TAGVHD is no barrier.

AB - Transfusion-associated graft versus host disease [TAGVHD] results from the engraftment of transfused immuno-competent cells in blood transfusion recipients, whose immune system is unable to reject them. All blood products containing viable, immuno-competent T cells have been implicated in TAGVHD. Presence of a "one-way HLA match between donor and recipient" is associated with a significantly increased risk of TAGVHD. Though sharing of haplotype is the most probable explanation, it is far from adequate. Since TAGVHD is not seen in patients with AIDS, and an acute GVHD-like syndrome has been noted in some identical twins and autologous (self) transplants, some other processes, possibly of an "autoimmune" nature are responsible for TAGVHD. Most of the cases have been reported from Japan. This clustering in space and time is rather intriguing. We offer here alternative hypothesis. Foetal and then neonatal lymphocytes exhibit tolerance towards donor cytotoxic T lymphocytes; and consequently very few cases of TAGVHD have been reported in neonates than expected. This tolerance is a part of altered immunology of pregnancy. We feel that it is possible to use maternal blood for transfusion to her newborn baby by following certain protocol and procedure and TAGVHD is no barrier.

KW - Autoimmune processes

KW - Fetomaternal tolerance

KW - Haplotype sharing

KW - Rarity in newborns

KW - TAGVHD

UR - http://www.scopus.com/inward/record.url?scp=84929576108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929576108&partnerID=8YFLogxK

U2 - 10.3109/14767058.2014.928859

DO - 10.3109/14767058.2014.928859

M3 - Article

C2 - 24871361

AN - SCOPUS:84929576108

VL - 28

SP - 700

EP - 704

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 6

ER -